First clinical trial of GABA/GAD focused exclusively on children with recent onset Type 1 diabetes
For the first time, humans with newly diagnosed Type 1 diabetes, or T1D, have received two treatments called GABA and GAD that have shown promise in animal studies and in isolated human pancreas islets. This investigator-initiated clinical trial, published in Nature Communications, focused exclusively on children with recent onset T1D.
Source: news-medical.net